acyclovir
Generic: acyclovir
Labeler: pd-rx pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
pd-rx pharmaceuticals, inc.
Dosage Form
TABLET
Routes
Active Ingredients
acyclovir 800 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
43063-589
Product ID
43063-589_4139742d-d092-121c-e063-6394a90a6221
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203834
Listing Expiration
2026-12-31
Marketing Start
2013-11-29
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
43063589
Hyphenated Format
43063-589
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA203834 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 800 mg/1
Packaging
- 10 TABLET in 1 BOTTLE, PLASTIC (43063-589-10)
- 30 TABLET in 1 BOTTLE, PLASTIC (43063-589-30)
- 35 TABLET in 1 BOTTLE, PLASTIC (43063-589-35)
- 50 TABLET in 1 BOTTLE, PLASTIC (43063-589-50)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4139742d-d092-121c-e063-6394a90a6221", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0343063589359"], "unii": ["X4HES1O11F"], "rxcui": ["197313"], "spl_set_id": ["e8a0f9f8-294f-4dd6-bd55-10a6253f1aa8"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET in 1 BOTTLE, PLASTIC (43063-589-10)", "package_ndc": "43063-589-10", "marketing_start_date": "20160804"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (43063-589-30)", "package_ndc": "43063-589-30", "marketing_start_date": "20150929"}, {"sample": false, "description": "35 TABLET in 1 BOTTLE, PLASTIC (43063-589-35)", "package_ndc": "43063-589-35", "marketing_start_date": "20150806"}, {"sample": false, "description": "50 TABLET in 1 BOTTLE, PLASTIC (43063-589-50)", "package_ndc": "43063-589-50", "marketing_start_date": "20150911"}], "brand_name": "Acyclovir", "product_id": "43063-589_4139742d-d092-121c-e063-6394a90a6221", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "43063-589", "generic_name": "Acyclovir", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "800 mg/1"}], "application_number": "ANDA203834", "marketing_category": "ANDA", "marketing_start_date": "20131129", "listing_expiration_date": "20261231"}